Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects

Clinical trial NCT04909723 · TERMINATED

Trial details

NCT number: NCT04909723
Sponsor: Novome Biotechnologies Inc
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Healthy Volunteers Enteric Hyperoxaluria

Start date: 2021-06-02
Primary completion: 2022-11-30
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.